UBS Group’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-35,053
Closed -$8.61M 11616
2022
Q3
$8.61M Sell
35,053
-12,164
-26% -$3.28M ﹤0.01% 1916
2022
Q2
$11.7M Buy
47,217
+11,432
+32% +$3.08M 0.01% 1694
2022
Q1
$11.9M Sell
35,785
-1,284
-3% -$395K 0.01% 1810
2021
Q4
$13.3M Buy
37,069
+8,599
+30% +$2.91M 0.01% 1897
2021
Q3
$9.27M Sell
28,470
-6,989
-20% -$2.37M ﹤0.01% 2082
2021
Q2
$11.1M Sell
35,459
-4,039
-10% -$1.24M ﹤0.01% 1945
2021
Q1
$12.6M Buy
39,498
+9,402
+31% +$3.01M 0.01% 1760
2020
Q4
$9.76M Sell
30,096
-19,835
-40% -$5.49M ﹤0.01% 1867
2020
Q3
$13.8M Buy
49,931
+11,806
+31% +$3.4M 0.01% 1423
2020
Q2
$9.21M Buy
38,125
+17,274
+83% +$3.47M 0.01% 1562
2020
Q1
$3.03M Buy
20,851
+9,297
+80% +$1.54M ﹤0.01% 2371
2019
Q4
$1.97M Sell
11,554
-12,834
-53% -$2.38M ﹤0.01% 3559
2019
Q3
$4.34M Sell
24,388
-15,114
-38% -$3.27M ﹤0.01% 2521
2019
Q2
$10.3M Sell
39,502
-20,832
-35% -$5.53M ﹤0.01% 1733
2019
Q1
$17.2M Buy
60,334
+9,491
+19% +$3.15M 0.01% 1240
2018
Q4
$16.5M Sell
50,843
-36,882
-42% -$12.8M 0.01% 1217
2018
Q3
$39.5M Buy
87,725
+5,741
+7% +$2.26M 0.02% 797
2018
Q2
$33.5M Buy
81,984
+15,213
+23% +$5.51M 0.02% 873
2018
Q1
$19.4M Buy
66,771
+6,740
+11% +$1.71M 0.01% 1187
2017
Q4
$11.3M Sell
60,031
-603
-1% -$113K 0.01% 1626
2017
Q3
$10.2M Buy
60,634
+16,323
+37% +$2.47M 0.01% 1605
2017
Q2
$6.35M Buy
44,311
+2,343
+6% +$315K ﹤0.01% 1918
2017
Q1
$5.25M Sell
41,968
-14,782
-26% -$1.71M ﹤0.01% 2052
2016
Q4
$6.39M Buy
56,750
+4,668
+9% +$541K ﹤0.01% 1874
2016
Q3
$6.7M Buy
52,082
+5,081
+11% +$609K ﹤0.01% 1751
2016
Q2
$5.14M Buy
47,001
+22,075
+89% +$2.2M ﹤0.01% 1935
2016
Q1
$2.36M Sell
24,926
-1,086
-4% -$91.7K ﹤0.01% 2535
2015
Q4
$2.35M Buy
26,012
+5,108
+24% +$433K ﹤0.01% 2649
2015
Q3
$1.94M Buy
20,904
+12,629
+153% +$1.11M ﹤0.01% 2772
2015
Q2
$544K Buy
8,275
+896
+12% +$59.5K ﹤0.01% 4049
2015
Q1
$528K Buy
7,379
+171
+2% +$9.28K ﹤0.01% 4100
2014
Q4
$275K Buy
+7,208
New +$227K ﹤0.01% 4736

Other funds holding ABMD